Parvizi Surgical Innovation announced an investment and partnership with Coracoid Solutions (CCS), an early-stage device company focused on sports medicine.
CCS is developing proprietary technology to address challenges inherent in acromioclavicular joint reconstruction.
Used in combination to repair disruption of the acromioclavicular/coracoclavicular ligaments, the products have clinically demonstrated an easy, safe and biomechanically sound reconstruction method. A minimally invasive, single-use device, the J-Pass™ allows safe passage under the coracoid and clavicle, while the M-Fix™ provides a wide prosthetic weave with a low-profile locking buckle. M-Fix can be incorporated with clavicular plating or used alone.
CCS is preparing for limited commercialization of its FDA 510(k)-cleared products. The platform will be further developed for other applications through the Parvizi/CCS partnership, including cerclage and soft tissue fixation.